Skip to content

Study · Not a test of the peptide alone · 2011

1 result

Mutational analysis of predicted extracellular domains of human growth hormone secretagogue receptor 1a.

Ueda T, Matsuura B, Miyake T, Furukawa S, Abe M, Hiasa Y, Onji M

Regulatory peptides18 Aug 2010Cited by 8 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01LabNot a test of GHRP-6 aloneIn vitro (cells)Mechanism

    In COS cells, receptor Cys residues at positions 116 and 198 and Glu¹⁸⁷ were critical for GHRP‑6 biological activity.

    In plain wordsIn cells, changes to specific receptor residues showed their importance for GHRP‑6 activity.

    Peptide
    GHRP-6
    Outcome
    Not applicableReceptor residues critical for biological activity
    Study

    n: not reported in source

    COS cells expressing mutated human GHS receptor 1a
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Cys residues in positions 116 and 198 in the first and second extracellular loops and the perimembranous Glu¹⁸⁷ residue in the second extracellular loop were critical for ghrelin and GHRP-6 biological activity.
    1 context sentence
    Summary · context
    Each construct was transiently expressed in COS cells, and characterized for ghrelin- and growth hormone releasing peptide (GHRP)-6-stimulated intracellular calcium responses and ghrelin radioligand binding.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.